Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial.
Nat Med · 2025-Dec · PMID 41057655
Radiographic progression-free survival
Fig. 2. Radiographic progression-free survival. a − c , Kaplan−Meier estimates of investigator-assessed radiographic progression-free survival in the BRCA subgroup ( n = 387) ( a ), the HRR effector subgroup ( n = 456) ( b ) and the intention-to-treat population ( n = 696) ( c ). Radiographic progression-free survival was compared between treatment groups using the stratified log-rank test. Hazard ratios and 95% confidence intervals (CIs) were estimated by stratified Cox proportional hazards models. Forest plot of prespecified subgroup analysis in the intention-to-treat population; dots represent hazard ratio estimates, and whiskers represent 95% CIs ( d ). Vertical bars are censor marks. ADT, androgen deprivation therapy; BFI-SF, Brief Pain Inventory (Short Form); NE, not estimable; PS, performance status.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 0.0988 | 0.0000 | 5.8537 | 96 | 73 |
| 1 | 2 | 0.0067 | 0.0864 | 0.1611 | 5.1220 | 97 | 74 |
| 1 | 3 | 0.0134 | 0.0864 | 0.3221 | 5.1220 | 98 | 74 |
| 1 | 4 | 0.0201 | 0.0864 | 0.4832 | 5.1220 | 99 | 74 |
| 1 | 5 | 0.0268 | 0.0864 | 0.6443 | 5.1220 | 100 | 74 |
| 1 | 6 | 0.0336 | 0.0864 | 0.8054 | 5.1220 | 101 | 74 |
| 1 | 7 | 0.0403 | 0.0864 | 0.9664 | 5.1220 | 102 | 74 |
| 1 | 8 | 0.0470 | 0.0864 | 1.1275 | 5.1220 | 103 | 74 |
| 1 | 9 | 0.0537 | 0.0864 | 1.2886 | 5.1220 | 104 | 74 |
| 1 | 10 | 0.0604 | 0.0864 | 1.4497 | 5.1220 | 105 | 74 |
| 1 | 11 | 0.0671 | 0.0864 | 1.6107 | 5.1220 | 106 | 74 |
| 1 | 12 | 0.1141 | 0.0864 | 2.7383 | 5.1220 | 113 | 74 |
| 1 | 13 | 0.1208 | 0.0864 | 2.8993 | 5.1220 | 114 | 74 |
| 1 | 14 | 0.1275 | 0.0864 | 3.0604 | 5.1220 | 115 | 74 |
| 1 | 15 | 0.1342 | 0.0864 | 3.2215 | 5.1220 | 116 | 74 |
| 1 | 16 | 0.1409 | 0.0864 | 3.3826 | 5.1220 | 117 | 74 |
| 1 | 17 | 0.1477 | 0.0864 | 3.5436 | 5.1220 | 118 | 74 |
| 1 | 18 | 0.1544 | 0.0864 | 3.7047 | 5.1220 | 119 | 74 |
| 1 | 19 | 0.1611 | 0.0864 | 3.8658 | 5.1220 | 120 | 74 |
| 1 | 20 | 0.1678 | 0.0864 | 4.0268 | 5.1220 | 121 | 74 |
| 1 | 21 | 0.1745 | 0.1852 | 4.1879 | 10.9756 | 122 | 66 |
| 1 | 22 | 0.1812 | 0.1852 | 4.3490 | 10.9756 | 123 | 66 |
| 1 | 23 | 0.1879 | 0.1852 | 4.5101 | 10.9756 | 124 | 66 |
| 1 | 24 | 0.1946 | 0.1852 | 4.6711 | 10.9756 | 125 | 66 |
| 1 | 25 | 0.2013 | 0.1852 | 4.8322 | 10.9756 | 126 | 66 |
| 1 | 26 | 0.2081 | 0.1852 | 4.9933 | 10.9756 | 127 | 66 |
| 1 | 27 | 0.2148 | 0.1852 | 5.1544 | 10.9756 | 128 | 66 |
| 1 | 28 | 0.2215 | 0.1852 | 5.3154 | 10.9756 | 129 | 66 |
| 1 | 29 | 0.2282 | 0.1852 | 5.4765 | 10.9756 | 130 | 66 |
| 1 | 30 | 0.2349 | 0.1852 | 5.6376 | 10.9756 | 131 | 66 |
| 1 | 31 | 0.2416 | 0.1852 | 5.7987 | 10.9756 | 132 | 66 |
| 1 | 32 | 0.2483 | 0.1852 | 5.9597 | 10.9756 | 133 | 66 |
| 1 | 33 | 0.2550 | 0.1852 | 6.1208 | 10.9756 | 134 | 66 |
| 1 | 34 | 0.2617 | 0.1852 | 6.2819 | 10.9756 | 135 | 66 |
| 1 | 35 | 0.2685 | 0.1852 | 6.4430 | 10.9756 | 136 | 66 |
| 1 | 36 | 0.2752 | 0.1852 | 6.6040 | 10.9756 | 137 | 66 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T17:15:36+00:00 |